Dauricine
Based on 3 publication(s) in Google Scholar
Dauricine, a bisbenzylisoquinoline alkaloid in Menispermum dauricum, possesses anti-inflammatory activity. Dauricine inhibits cell proliferation and invasion, and induces apoptosis by suppressing NF-κB activation in a dose- and time-dependent manner in colon cancer.
For research use only. We do not sell to patients.
- Purity: 99.68%
- CAS No.: 524-17-4
- Formula: C38H44N2O6
- Molecular Weight:624.77
-
Storage:
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Publications Citing Use of MedChemExpress (MCE) Dauricine
More-
Cell Proliferation/Viability Assay
-
RT-PCR
-
WB
-
Histological Imaging/Staining
-
Cell Imaging/Staining
Biological Activity
Dauricine (0-20 μM, 8 days) inhibits cell growth of HCT116, HCT8, SW620, and SW480 cells[1].
Dauricine (0-20 μM, 12 and 24 h) causes G1 phase cell-cycle arrest in HCT116 cells[1].
Dauricine (0-20 μM, 36 h) induces cell apoptosis and inhibits cell invasion in HCT116 cells[1].
Dauricine (0-20 μM, 6 h) inhibits the activation of NF-κB signaling pathway in HCT116 cells[1].
Dauricine (1 and 2 μg/mL, 24 h) inhibits glucose glycolysis and increased oxidative phosphorylation in HepG2 and Huh-7 cells[3].
Dauricine (2 μg/mL, 48 h) increases the sensitivities of HCC cell lines to both Cisplatin (HY-17394) and Sorafenib (HY-10201)[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HCT 116
-
Concentration:5, 10, 20 μM
-
Incubation Time:36 h
-
Result:Showed he percentages of apoptotic rate of 7.8% to 14.4%, 19.8%, and 29.7% at 5, 10, and 20 μM.
Increased the accumulation of cleavage PARP and caspase3.
-
Cell Line:HCT 116
-
Concentration:5, 10, 20 μM
-
Incubation Time:36 h
-
Result:Inhibited the TNF (0.5 nM)-induced phosphorylation and nuclear translocation of p65.
Dauricine (1 or 10 mg/kg, i.p.) ameliorates cognitive impairment, reduces Aβ Accumulation and Tau hyperphosphorylation in 3xTg-Alzheimer's Disease mice[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:HCT116 xenograft mouse model[1]
-
Dosage:40 mg/kg
-
Administration:s.c., every 2-day. for 9 days
-
Result:Inhibited colonic tumor growth completely at 9 days, with little effect on body weight.
Chemical Information
-
CAS No. 524-17-4
-
Appearance Solid
-
Molecular Weight 624.77
-
Formula C38H44N2O6
-
Color White to off-white
-
SMILES
OC1=CC=C(C[C@H]2N(C)CCC3=C2C=C(OC)C(OC)=C3)C=C1OC4=CC=C(C[C@H]5N(C)CCC6=C5C=C(OC)C(OC)=C6)C=C4
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Publications (3)
-
Journal Impact Factor
-
Most Recent
-
Biochem Pharmacol
Dauricine regulates prostate cancer progression by inhibiting PI3K/AKT-dependent M2 polarization of macrophages. [Abstract]2023 Nov:217:115838. PMID: 37778445 -
Food Sci Nutr
Dauricine Inhibits Macrophages M2 Polarization and Regulates the Progression and Ferroptosis via HCK/IDO1 in Urinary Bladder Cancer. [Abstract]2025 Dec 21;13(12):e71341. PMID: 41438182
Dauricine purchased from MedChemExpress. Usage Cited in: Food Sci Nutr. 2025 Dec 21;13(12):e71341. [Abstract]
CCK-8 assay of cell viability of RAW264.7 cells and BLCA cells treated with different concentrations of Dauricine (DAU) (0, 5, 10, 20, 40, and 80 μM) for 24 h.
Dauricine purchased from MedChemExpress. Usage Cited in: Food Sci Nutr. 2025 Dec 21;13(12):e71341. [Abstract]
qRT‐PCR analysis of HCK in RAW264.7 cells cultured with BLCA cell supernatants with or without Dauricine (DAU) (5 μM).
Dauricine purchased from MedChemExpress. Usage Cited in: Food Sci Nutr. 2025 Dec 21;13(12):e71341. [Abstract]
Western blot of EMT markers in TAMs‐induced BLCA cells for 24 h with or without Dauricine (DAU) (5 μM) treatment.
Dauricine purchased from MedChemExpress. Usage Cited in: Food Sci Nutr. 2025 Dec 21;13(12):e71341. [Abstract]
Representative images of tumors IHC analysis treated with Dauricine (DAU) (10 mg/kg, i.p.).
Dauricine purchased from MedChemExpress. Usage Cited in: Food Sci Nutr. 2025 Dec 21;13(12):e71341. [Abstract]
Fluorescent image analysis shows that ROS levels were significantly reduced in the M2‐like TAM‐CM group but rebounded after Dauricine (DAU) (5 μM) treatment.
-
Solvent & Solubility
DMSO : 100 mg/mL (160.06 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (4.00 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (4.00 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL. * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation
-
Data Sheet (278 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
[1]. Yang Z, et al. Dauricine induces apoptosis, inhibits proliferation and invasion through inhibiting NF-kappaB signaling pathway in colon cancer cells. J Cell Physiol. 2010 Oct;225(1):266-75. [Content Brief]
[2]. Chen C, et al. Dauricine Attenuates Spatial Memory Impairment and Alzheimer-Like Pathologies by Enhancing Mitochondrial Function in a Mouse Model of Alzheimer's Disease. Front Cell Dev Biol. 2021 Feb 5;8:624339. [Content Brief]
[3]. Li W, et al. Dauricine upregulates the chemosensitivity of hepatocellular carcinoma cells: Role of repressing glycolysis via miR-199a:HK2/PKM2 modulation. Food Chem Toxicol. 2018 Nov;121:156-165. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.6006 mL | 8.0029 mL | 16.0059 mL | 40.0147 mL |
| 5 mM | 0.3201 mL | 1.6006 mL | 3.2012 mL | 8.0029 mL | |
| 10 mM | 0.1601 mL | 0.8003 mL | 1.6006 mL | 4.0015 mL | |
| 15 mM | 0.1067 mL | 0.5335 mL | 1.0671 mL | 2.6676 mL | |
| 20 mM | 0.0800 mL | 0.4001 mL | 0.8003 mL | 2.0007 mL | |
| 25 mM | 0.0640 mL | 0.3201 mL | 0.6402 mL | 1.6006 mL | |
| 30 mM | 0.0534 mL | 0.2668 mL | 0.5335 mL | 1.3338 mL | |
| 40 mM | 0.0400 mL | 0.2001 mL | 0.4001 mL | 1.0004 mL | |
| 50 mM | 0.0320 mL | 0.1601 mL | 0.3201 mL | 0.8003 mL | |
| 60 mM | 0.0267 mL | 0.1334 mL | 0.2668 mL | 0.6669 mL | |
| 80 mM | 0.0200 mL | 0.1000 mL | 0.2001 mL | 0.5002 mL | |
| 100 mM | 0.0160 mL | 0.0800 mL | 0.1601 mL | 0.4001 mL |